Last $2.34 USD
Change Today -0.04 / -1.68%
Volume 685.8K
ATRS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for antares pharma inc (ATRS)

Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
Dec 31
2013
4 Year
Trend
NET INCOME-6.1-4.4-11.4-20.5
Depreciation & Amortization0.10.10.10.4
Amortization of Goodwill and Intangible Assets0.10.10.10.1
DEPRECIATION & AMORTIZATION, TOTAL0.20.20.20.5
(Gain) Loss from Sale of Asset0.10.00.1--
(Gain) Loss on Sale of Investment--0.00.10.2
Asset Writedown & Restructuring Costs------0.1
Change in Accounts Receivable0.2-1.30.31.2
Change in Inventories0.1-0.6-0.1-5.5
Change in Accounts Payable-0.10.40.72.5
Change in Unearned Revenues-2.41.5-3.33.2
Change in Other Working Capital0.70.50.90.9
CASH FROM OPERATIONS-6.1-1.9-10.5-15.0
Capital Expenditure-0.1-0.4-3.3-2.7
Sale of Property, Plant, and Equipment0.00.0----
Sale (Purchase) of Intangible Assets-0.1-0.2-0.2-0.4
Investments in Marketable & Equity Securities---15.1-18.22.9
CASH FROM INVESTING-0.2-15.6-21.7-0.3
Issuance of Common Stock2.527.364.92.3
Other Financing Activities---0.20.0-0.1
CASH FROM FINANCING2.527.164.92.2
Foreign Exchange Rate Adjustments0.10.00.00.0
NET CHANGE IN CASH-3.79.532.7-13.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATRS:US $2.34 USD -0.04

ATRS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biolase Inc $2.56 USD -0.0001
Cerus Corp $5.34 USD -0.12
Pluristem Therapeutics Inc $3.72 USD +0.04
SurModics Inc $22.92 USD +0.64
Uroplasty Inc $1.23 USD -0.04
View Industry Companies
 

Industry Analysis

ATRS

Industry Average

Valuation ATRS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.4x
Price/Book 6.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTARES PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.